Skip to main content
. 2022 Oct 26;9(35):2204513. doi: 10.1002/advs.202204513

Table 1.

Univariate and multivariate Cox‐regression analysis of prognostic factors for CRC patients

Low expression High expression
HR 95% CI P HR 95% CI P
Univariate analysis
TNM stage
I and II 1 1
III and IV 1.038 (0.347, 3.108) 0.947 1.025 (0.344, 3.035) 0.965
Tumor location
Colon 1 1
Rectum 1.693 (0.795, 4.664) 0.146 0.997 (0.430, 2.314) 0.995
Differentiation
Well/ Moderate 1 1
Poor 1.419 (0.472, 4.265) 0.534 1.162 (0.395, 3.422) 0.785
Chemotherapy
Control 1 1
Oxaliplatin 0.291 (0.115,0.736) 0.009 a) 1.142 (0.474, 2.752) 0.767
Age 1.047 (1.004,1.091) 0.031 a) 1.005 (0.974, 1.0369) 0.733
Multivariate analysis
Chemotherapy
Control 1
Oxaliplatin 0.320 (0.124,0.824) 0.018 a)
Age 1.039 (0.996,1.083) 0.073
a)

p < 0.05.